XML 32 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Share Owners' Equity
3 Months Ended
Mar. 31, 2022
Share Owners' Equity  
Share Owners' Equity

11. Share Owners’ Equity

The activity in share owners’ equity for the three months ended March 31, 2022 and 2021 is as follows:

Share Owners’ Equity of the Company

    

    

    

    

    

Accumulated

    

    

 

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

Stock

Par Value

Stock

Earnings

Loss

Interests

Equity

Balance on January 1, 2022

$

2

$

3,090

(701)

$

301

$

(1,972)

$

107

$

827

Reissuance of common stock (0.2 million shares)

(2)

5

 

3

Shares repurchased (0.8 million shares)

(10)

 

(10)

Stock compensation (0.4 million shares)

7

 

7

Net earnings

88

34

 

122

Other comprehensive income

151

5

 

156

Other

(3)

(3)

Balance on March 31, 2022

$

2

$

3,085

$

(699)

$

389

$

(1,821)

$

146

$

1,102

Share Owners’ Equity of the Company

    

    

    

    

    

Accumulated

    

    

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

    

Stock

    

Par Value

    

Stock

Earnings

Loss

Interests

Equity

 

Balance on January 1, 2021

$

2

$

3,129

$

(714)

$

152

$

(2,272)

$

104

$

401

Reissuance of common stock (0.2 million shares)

(2)

4

 

2

Stock compensation (0.3 million shares)

4

 

4

Net loss

(97)

6

 

(91)

Other comprehensive loss

(48)

(4)

 

(52)

Other

19

(2)

(19)

(2)

Balance on March 31, 2021

$

2

$

3,150

$

(712)

$

36

$

(2,320)

$

106

$

262

During the three months ended March 31, 2022 the Company purchased 764,501 shares of its common stock for approximately $10 million. The share purchases were pursuant to a $150 million anti-dilutive share repurchase program authorized by the Company’s Board of Directors that is intended to offset stock-based compensation provided to the Company’s directors, officers, and employees. Approximately $100 million remained available for purchases under this program as of March 31, 2022.

The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows:

Shares Outstanding (in thousands)

 

March 31,

December 31,

March 31,

 

    

2022

    

2021

    

2021

 

Shares of common stock issued (including treasury shares)

 

187,617

187,752

189,796

Treasury shares

 

31,401

31,397

31,884